A Biorepository for the Center for Multiple Sclerosis and Autoimmune Neurology

Overview

About this study

The purpose of this study is to establish a repository consisting of clinical information, radiological data, serum, peripheral blood lymphocytes, plasma, cerebrospinal fluid (CSF), urine, stool, DNA and tissue specimens collected from patients who have central nervous system (CNS)  inflammatory diseases. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • Male or female
  • Has inflammatory disease
    • Controls will not have an inflammatory disease
  • All ages are being enrolled
    • For skin punch biopsies, participants must be 18 years or older
  • Must be able to give informed consent or have an appropriate representative available to do so.

Exclusion Criteria

  • Institutionalized (i.e., Federal Medical Prison)
  • Allergy to lidocaine, bupivacaine, and/or epinephrine for skin punch biopsy only

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Sean Pittock, M.D.

Open for enrollment

Contact information:

Jessica Sagen M.A.

Sagen.Jessica@mayo.edu

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Sean Pittock, M.D.

Closed for enrollment

Contact information:

No Contact

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available